Tinzaparin Tedavisinin Oral Yassı Hücreli Karsinoma Çıplak Fare Modelinde BAX ve CCNB1 Gen Anlatımları Üzerindeki Etkisi

Journal Title: Turkish Journal of Immunology - Year 2018, Vol 6, Issue 3

Abstract

The Effect of Tinzaparin Treatement on BAX and CCNB1 Gene Expression in an Oral Squamous Cell Carcinoma Nude Mice Model Introduction: This study aims to evaluate the effect of tinzaparin treatment on the expression of proapoptotic BAX and cell cycle G2/M phase regulator CCNB1 genes in an oral squamous cell carcinoma (OSCC) nude mice model. Materials and Methods: Total of 11 nude mice at 4–6 weeks of age, composed of three groups [tinzaparin treated (n=4), positive control (n=4), negative control (n=3)], were used to create an orthotopic OSCC mice model. Human tongue cancer cell line OSC-19 was utilized to create this in vivo model. After 21 days, the mice were sacrificed and tumors were quantified for BAX and CCNB1 expression utilizing quantitative real-time polimerase chain reaction (qRT-PCR). Livak method normalized for control samples revealed fold-changes utilizing ACTB housekeeping gene. Statistical significance was tested by non-parametric Mann-Whitney U test, where P<0.05 was considered significant. Results: Two mice in positive control and tinzaparin groups did not develop tumors. Available tumors showed decreased BAX and CCNB1 expressions with low statistical significance, when compared to the control group. Conclusion: These preliminary results indicate a deregulated cell cycle control without an effect on apoptosis. More mice should be included to significantly state the effect of tinzaparin treatment in OSCC mice model. Keywords: Oral squamous cell carcinoma, nude mice, qRT-PCR, BAX, CCNB1

Authors and Affiliations

Feyza TUNCER, Yeliz EKİCİ, Betül AKÇA

Keywords

Related Articles

Multi-Epitope Cluster Ep85B within the Mycobacterial Protein Ag85B Elicits Cell-Mediated and Humoral Responses in Mice

Introduction: Epitope-based vaccines present a rational alternative to conventional concepts of vaccine design, particularly for combating complex infectious agents such as tuberculosis (TB). We have previously identifie...

Multiple Sclerosis Under Attack; Shehata’s Therapy

Multiple sclerosis is an autoimmune disease characterized by inflammatory demylination of the nerves in the central nervous system (brain and spinal cord). Depending on the attacked sites, the disease manifestations vary...

Patient-Oriented Application of New Monoclonal Antibodies for Severe Asthma

Asthma is a chronic lung disease that occurs due to many genetic and environmental factors. In the Global Initiative for Asthma (GINA) guideline, anti-immunoglobulin E (anti-IgE) (omalizumab) for patients with allergic a...

Soybean Extract Suppresses B Cell Activation Through TLR3/TLR4 in High Fat-High Fructose Diet Mice

Introduction: The relationship between B cells and Toll-like Receptors (TLRs) under high fat−high fructose diet (HFFD) is still poorly understood. Isoflavone content from soybean can be modified by using biotic and abiot...

Expression of Tumor Necrosis Factor-α and Interleukin-6 in Chronic Suppurative Otitis Media

Introduction: Chronic suppurative otitis media (CSOM) with cholesteatoma is decribed by keratin epithelial invasion in the middle ear and osteolysis in both of the ear bones and the temporal bone. Some inflammatory facto...

Download PDF file
  • EP ID EP450947
  • DOI 10.25002/tji.2018.977
  • Views 91
  • Downloads 0

How To Cite

Feyza TUNCER, Yeliz EKİCİ, Betül AKÇA (2018). Tinzaparin Tedavisinin Oral Yassı Hücreli Karsinoma Çıplak Fare Modelinde BAX ve CCNB1 Gen Anlatımları Üzerindeki Etkisi. Turkish Journal of Immunology, 6(3), 131-135. https://europub.co.uk./articles/-A-450947